From Lab to Patient
The journey of a medicine assessed by EMA
Social Media and M-Health Data
New and innovative technologies have led to an explosion in data coming from novel data sources that have not been widely utilized within medicines regulation
Regulators’ advice can make a difference for faster patient access to highly innovative therapies
Faster patient access to highly innovative therapies
Good use of paracetamol and nonsteroidal anti-inflammatory drugs (NSAIDs): the ANSM wants to strengthen the role of pharmacist’s advice
ANSM wants to strengthen the pharmacist’s advisory role for the use of Paracetamol and nonsteroidal anti-inflammatory drugs
First vaccine to protect against Ebola
First vaccine for active immunisation of individuals aged 18 years and older at risk of infection with the Ebola virus.
Access to therapeutic innovation, ANSM perpetuates its accelerated authorization circuits for clinical trials of so-called “fast-track” drugs
ANSM has decided to perpetuate the two accelerated clinical trial authorization devices (Fast Track)
Pharmya will be present at the International Pharmacovigilance Day conference in Barcelona on 12th and 13th of June 2019. Meet us there!
Pharmya will be present at the International Pharmacovigilance Day conference in Barcelona on 12th and 13th of June 2019. Meet us there!